Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan,
Nephron. 2020;144 Suppl 1:102-107. doi: 10.1159/000511558. Epub 2020 Nov 26.
We report a case of graft intolerance syndrome in which transplant nephrectomy was performed 11 years after kidney transplantation. A 46-year-old man was admitted to our hospital in February 2018 with a mild fever, left lower abdominal pain, and gross hematuria with enlargement of the transplanted kidney. Urinary tract infection was ruled out. Because the symptoms developed after the immunosuppressants had been stopped after kidney graft loss, graft intolerance syndrome was suspected. He had lost his graft in 2016 and had stopped all immunosuppressants since January of 2017. Immunosuppressive therapy was intensified, and steroid half-pulse therapy was added for 3 days. After the steroid pulse therapy, the C-reactive protein (CRP) decreased from 6.47 mg/dL to 0.76 mg/dL, but there was little improvement in the symptoms, and the CRP then increased to 4.44 mg/dL. Transplant nephrectomy was performed in March 2018. Postoperatively, the symptoms disappeared without the administration of immunosuppressants, and the CRP decreased. Pathologically, the resected kidney graft showed persistent active allograft rejection with severe endarteritis, transplant glomerulopathy, and diffuse interstitial fibrosis. Massive thrombi occluded the large arteries, and there was extensive hemorrhagic cortical necrosis. Transplant nephrectomy is uncommon in patients >6 months after transplantation. However, even if more time has passed since transplantation, as in this case, transplant nephrectomy may be a valid option in some cases of severe graft intolerance syndrome.
我们报告了一例移植肾不耐受综合征病例,该病例在肾移植后 11 年进行了移植肾切除术。一名 46 岁男性于 2018 年 2 月因轻度发热、左下腹痛和伴移植肾增大的肉眼血尿而入院。排除了尿路感染。由于在移植肾丢失后停用免疫抑制剂后出现症状,故怀疑为移植肾不耐受综合征。他于 2016 年丢失了移植肾,自 2017 年 1 月以来已停止使用所有免疫抑制剂。强化免疫抑制治疗,并加用激素半量冲击治疗 3 天。激素冲击治疗后,C 反应蛋白(CRP)从 6.47mg/dL 降至 0.76mg/dL,但症状改善不大,CRP 随后升至 4.44mg/dL。2018 年 3 月行移植肾切除术。术后,在未使用免疫抑制剂的情况下症状消失,CRP 下降。病理检查显示,切除的移植肾显示持续性同种异体移植排斥反应活跃,伴有严重动脉炎、移植肾小球病和弥漫性间质纤维化。大量血栓阻塞大动脉,皮质广泛出血性坏死。移植肾切除术在移植后 >6 个月的患者中并不常见。然而,即使在移植后经过更长时间,如本例中,在某些严重移植肾不耐受综合征的情况下,移植肾切除术可能是一种有效的选择。